+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Gastrointestinal Drugs Market Research Reports

From
Zollinger Ellison Syndrome - Epidemiology Forecast - 2032 - Product Thumbnail Image

Zollinger Ellison Syndrome - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Peptic Ulcer Hemorrhage - Epidemiology Forecast - 2032 - Product Thumbnail Image

Peptic Ulcer Hemorrhage - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Malignant Ascites - Epidemiology Forecast - 2032 - Product Thumbnail Image

Malignant Ascites - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Inguinal Hernia - Epidemiology Forecast - 2032 - Product Thumbnail Image

Inguinal Hernia - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
From
Esophageal Achalasia - Epidemiology Forecast - 2032 - Product Thumbnail Image

Esophageal Achalasia - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Emesis - Epidemiology Forecast - 2032 - Product Thumbnail Image

Emesis - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Fecal Incontinence - Epidemiology Forecast - 2032 - Product Thumbnail Image

Fecal Incontinence - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Chronic Constipation - Epidemiology Forecast - 2032 - Product Thumbnail Image

Chronic Constipation - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
Barett Esophagus - Epidemiology Forecast - 2032 - Product Thumbnail Image

Barett Esophagus - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Overactive Bowel Disease - Epidemiology Forecast - 2032 - Product Thumbnail Image

Overactive Bowel Disease - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Oral Dysplasia - Epidemiology Forecast - 2032 - Product Thumbnail Image

Oral Dysplasia - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Chronic Cutaneous Ulcers - Epidemiology Forecast - 2032 - Product Thumbnail Image

Chronic Cutaneous Ulcers - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Intestinal Mucosal Injury - Epidemiology Forecast - 2032 - Product Thumbnail Image

Intestinal Mucosal Injury - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Post-Operative Nausea & Vomiting - Epidemiology Forecast - 2032 - Product Thumbnail Image

Post-Operative Nausea & Vomiting - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Pouchitis - Epidemiology Forecast - 2032 - Product Thumbnail Image

Pouchitis - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Digestive System Fistula - Epidemiology Forecast - 2032 - Product Thumbnail Image

Digestive System Fistula - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Loading Indicator

The Gastrointestinal Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat diseases and disorders of the gastrointestinal tract. These drugs are used to treat conditions such as irritable bowel syndrome, Crohn's disease, ulcerative colitis, and gastroesophageal reflux disease. Commonly prescribed drugs include antacids, proton pump inhibitors, and H2 receptor antagonists. The Gastrointestinal Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Pfizer, GlaxoSmithKline, Merck & Co., AstraZeneca, and Novartis. These companies are constantly developing new drugs and treatments to meet the needs of patients. Show Less Read more